共 13 条
[1]
Nichol K.L., Mendelman P.M., Mallon K.P., Et al., Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: A randomized controlled trial, Journal of the American Medical Association, 282, pp. 137-144, (1999)
[2]
Jackson L.A., Holmes S.J., Mendelman P.M., Et al., Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist (TM), administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions, Vaccine, 17, pp. 1905-1909, (1999)
[3]
Clements M.L., Makhene M.K., Karron R.A., Murphy B.R., Steinhoff M.C., Et al., Effective immunization with live attenuated influenza A virus can be achieved in early infancy, Journal of Infectious Diseases, 173, pp. 44-51, (1996)
[4]
Gorse G.J., Otto E.E., Powers D.C., Chambers G.W., Eickhoff C.S., Et al., Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly, Journal of Infectious Diseases, 173, pp. 285-290, (1996)
[5]
King J.C. Jr., Lagos R., Bernstein D.I., Piedra P.A., Kotloff K., Et al., Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children, Journal of Infectious Diseases, 177, pp. 1394-1397, (1998)
[6]
Gruber W., Belshe R., Mendelman P., Et al., Immunologic response to heterotypic H3N2 strains after live intranasal or inactivated intramuscular influenza vaccine in children, Clinical Infectious Diseases, 27, (1998)
[7]
Boyce T.G., Gruber W.C., Coleman-Dockery S.D., Sannella E.C., Reed G.W., Et al., Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children, Vaccine, 18, pp. 82-88, (1999)
[8]
Longini I.M. Jr., Halloran M.E., Nizam A., Wolff M., Mendelman P.M., Et al., Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: Implications for influenza epidemic control, Vaccine, 18, pp. 1902-1909, (2000)
[9]
Belshe R.B., Gruber W.C., Mendelman P.M., Cho I., Reisinger K., Et al., Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine, Journal of Pediatrics, 136, pp. 168-175, (2000)
[10]
Belshe R.B., Mendelman P.M., Treanor J., King J., Gruber W.C., Et al., The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children, New England Journal of Medicine, 338, pp. 1405-1412, (1998)